Internationally Known Oncology Surgeon Frank E. Johnson Joins GenoMed's Scientific Advisory Board
ST. LOUIS, Sept. 3 /PRNewswire-FirstCall/ -- GenoMed, Inc. (OTC Pink Sheets: GMED) ("the Company" or "GenoMed"), a St. Louis, Missouri-based medical genomics biotechnology company, announced today that Dr. Frank E. Johnson has joined its Scientific Advisory Board.
Dr. Johnson is a leading academic surgeon with special expertise in cancer surgery. He is currently Professor of Surgery at St. Louis University School of Medicine, and Chief of Surgery at the St. Louis VA Medical Center.
Dr. Johnson received both his undergraduate degree (with Phi Beta Kappa honors) and his M.D. degree from the University of Minnesota. He then trained in general and oncologic surgery at UCLA, the University of Washington in Seattle, and the University of Colorado in Denver. He spent four years as a Surgical Research Fellow, first at the University of California, San Francisco, and then at the Memorial Sloan-Kettering Cancer Center in New York. His surgical training was interrupted for two years in 1969-71. He spent those two years on active duty as a Navy surgeon, in part with the First Marine Division in DaNang, Vietnam, for which he received the Bronze Star and the Navy Commendation Medal.
Dr. Johnson is the author of over 200 journal articles and a dozen books and book chapters. He has been featured in 14 videos demonstrating advanced surgical techniques, and he received an award for excellence in student teaching for three years in a row at St. Louis University School of Medicine. He is on the editorial boards of 6 surgical journals, and a member of 31 professional societies, including serving as co-founder of the Children's Heart Fund in Minneapolis, a non-profit organization now known as Children's Heart Link. As a Visiting Professor supported by the Royal College of Surgeons in 1986-87 and by the Central Surgical Association Foundation in 1995, he has taught at more than a dozen of the finest surgical hospitals in England, Wales, Italy, and the Netherlands. In 1982, he was a Visiting Professor in Brazil. His scientific interests range from the molecular aspects of cancer to the cost of cancer surgery.
Dr. David Moskowitz, GenoMed's Chairman, said, "We are honored to have Dr. Johnson agree to join our Scientific Advisory Board. He is a surgeon with impeccable training, outstanding skills as an educator, and an enormous breadth of scientific interests. He is extremely well-respected nationally and internationally."
Dr. Moskowitz added, "Perhaps the most unique thing about Dr. Johnson is that, despite his extraordinary skill at general surgery and cancer surgery in particular, he is committed to early detection of disease using the most advanced technology possible. He would much rather prevent disease than operate on it. He is an expert on the cost of health care, and is committed to improving patient outcomes while reducing healthcare costs. Dr. Johnson brings to GenoMed's Scientific Advisory Board the ability to see the clinical 'Big Picture.'"
GenoMed, Inc. is a medical genomics company whose mission is to improve patient outcomes by identifying the genes that cause disease. A recent St. Louis Business Journal article (http://www.stlouis.bizjournals.com/stlouis/stories/2002/05/13/story8.html) reported that the company has applied for patents based on its finding that the ACE gene is associated with over 40 common, age-related diseases. The Company has filed patent applications on its new treatments for both human and veterinary use. A video version of the company's treatment results for chronic kidney failure is available at 216.234.225.2
For questions, please contact Krissy Fischer, tel. 1-877-GENOMED, FAX 314-977-0042, email: kfischer@genomedics.com, or visit GenoMed at www.genomedics.com .
SOURCE GenoMed, Inc.
CONTACT: Krissy Fischer of GenoMed, Inc., +1-877-436-6633, or fax,
+1-314-977-0042, or kfischer@genomedics.com
Web site: genomedics.com |
